Themis Medicare LimitedNSE: THEMISMED

Press Release Mar 21 2022

· Issued by Themis Medicare Limited

Themis Medicare Limited has informed the Exchange about press release dated 21-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India

View Attachment

Company analysis

Earlier from Themis Medicare

All Themis Medicare news releases